Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch
  

Cytomx Therapeutics Inc patents

Recent patent applications related to Cytomx Therapeutics Inc. Cytomx Therapeutics Inc is listed as an Agent/Assignee. Note: Cytomx Therapeutics Inc may have other listings under different names/spellings. We're not affiliated with Cytomx Therapeutics Inc, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "C" | Cytomx Therapeutics Inc-related inventors




Date Cytomx Therapeutics Inc patents (updated weekly) - BOOKMARK this page
08/24/17Proproteins and methods of use thereof
07/20/17Matriptase and u-plasminogen activator substrates and other cleavable moieties and methods of use thereof
07/13/17Activatable antibodies that bind epidermal growth factor receptor and methods of use thereof
04/06/17Activatable antibodies that bind epidermal growth factor receptor and methods of use thereof
03/23/17Modified antibody compositions, methods of making and using thereof
03/16/17Compositions and methods for conjugating activatable antibodies
02/16/17Anti-pd1 antibodies, activatable anti-pd1 antibodies, and methods of use thereof
01/05/17Activatable antibodies that bind interleukin-6 receptor and methods of use thereof
12/08/16Anti-cd166 antibodies, activatable anti-cd166 antibodies, and methods of use thereof
12/08/16Anti-itga3 antibodies, activatable anti-itga3 antibodies, and methods of use thereof
12/08/16Anti-cd71 antibodies, activatable anti-cd71 antibodies, and methods of use thereof
10/27/16Anti-pdl1 antibodies, activatable anti-pdl1 antibodies, and methods of use thereof
10/06/16Matrix metalloprotease-cleavable and serine protease-cleavable substrates and methods of use thereof
09/15/16Protease-resistant systems for polypeptide display and methods of making and using thereof
08/11/16Modified antibody compositions, methods of making and using thereof
07/28/16Antibodies specific for urokinase-type plasminogen activator and methods of use thereof
07/14/16Anti-jagged 1/jagged 2 cross-reactive antibodies, activatable anti-jagged antibodies and methods of use thereof
07/07/16Activatable antibodies that bind epidermal growth factor receptor and methods of use thereof
07/07/16Anti-cd3 antibodies, activatable anti-cd3 antibodies, multispecific anti-cd3 antibodies, multispecific activatable anti-cd3 antibodies, and methods of using the same
05/05/16Activatable binding polypeptides and methods of identification and use thereof
08/06/15Matriptase and u-plasminogen activator substrates and other cleavable moieties and methods of use thereof
07/23/15Proproteins and methods of use thereof
06/11/15Antibodies that bind activatable antibodies and methods of use thereof
04/30/15Activatable antibodies that bind epidermal growth factor receptor and methods of use thereof
03/26/15Matrix metalloproteinase substrates and other cleavable moieties and methods of use thereof
03/19/15Multispecific antibodies, multispecific activatable antibodies and methods of using the same
01/01/15Compositions and methods for conjugating activatable antibodies
12/11/14Activatable antibodies that bind interleukin-6 receptor and methods of use thereof
04/25/13Proproteins and methods of use thereof







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Cytomx Therapeutics Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Cytomx Therapeutics Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';